CD8A and cancer: Along the same lines, EPIC analyses revealed that the numbers of CD8+T cells, CD4+T cells, B cells, myeloid dendritic cells, cancer-associated fibroblasts, and hematopoietic stem cells, and immune, stromal, and microenvironment scores were higher in the low-risk group.